Bioelectrical Impedance Phase Angle and Morbidity and Mortality in Critically Ill Children

Imagem de Miniatura
Arquivos
art_ZAMBERLAN_Bioelectrical_Impedance_Phase_Angle_and_Morbidity_and_Mortality_2019.PDF (1.09 MB)
Citações na Scopus
22
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
Citação
NUTRITION IN CLINICAL PRACTICE, v.34, n.1, p.163-171, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BackgroundNutrition markers may be useful for diagnosis and monitoring and, also, as additional indicators of estimating death risk. We tested the association of body composition indicators (mid-upper arm circumference and phase angle) with pediatric intensive care unit (PICU) length of stay and mortality in critically ill pediatric patients. MethodsData from children aged 2 months-18 years were collected, and bioelectrical impedance was performed to obtain phase angle. Severity was evaluated by scoring the Pediatric Index of Mortality. Descriptive statistics were reported for nominal variables. Receiver operating characteristic curve was used to analyze the association of phase angle with 30-day mortality and to find the best cutoff. Survival probabilities and PICU length of stay were estimated using the Kaplan-Meier method. ResultsWe evaluated 247 children with a median age of 4.8 years whose main cause of admission was sepsis. Survival curves showed higher survival in patients with phase angle >2.8 degrees compared with patients with phase angle 2.8 degrees (P<.0001). Kaplan-Meier time-to-event analysis showed that children with lower phase angle values were more likely to remain in the PICU (hazard ratio, 1.84; P=.003). Lower survival was also observed in patients who presented mid-upper arm circumference values 5th percentile (P<.03). ConclusionsMid-upper arm circumference and phase angle were associated with mortality and morbidity in critically ill children, suggesting that these parameters may be useful not only for nutrition diagnosis and monitoring, but also as an additional indicator in estimating prognosis.
Palavras-chave
body composition, electrical impedance, mortality, nutrition assessment, pediatric intensive care units, phase angle, prognosis
URI
https://observatorio.fm.usp.br/handle/OPI/31189
Referências
  1. Azevedo ZMA, 2013, CLIN NUTR, V32, P824, DOI 10.1016/j.clnu.2013.01.011
  2. Alves FD, 2016, CLIN NUTR, V35, P1530, DOI 10.1016/j.clnu.2016.04.007
  3. Barbosa-Silva MCG, 2005, CURR OPIN CLIN NUTR, V8, P311, DOI 10.1097/01.mco.0000165011.69943.39
  4. Barbosa-Silva MCG, 2003, NUTRITION, V19, P422, DOI 10.1016/S0899-9007(02)00932-2
  5. Bechard LJ, 2016, CRIT CARE MED, V44, P1530, DOI 10.1097/CCM.0000000000001713
  6. Belarmino G, 2017, WORLD J HEPATOL, V9, P401, DOI 10.4254/wjh.v9.i7.401
  7. Briassoulis G, 2014, INTENS CARE MED, V40, P120, DOI 10.1007/s00134-013-3123-5
  8. Chomtho S, 2006, PEDIATR RES, V59, P860, DOI 10.1203/01.pdr.0000219395.83159.91
  9. CHUMLEA WMC, 1994, J AM DIET ASSOC, V94, P1385, DOI 10.1016/0002-8223(94)92540-2
  10. Craig E, 2014, ARCH DIS CHILD, V99, P763, DOI 10.1136/archdischild-2013-305137
  11. de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548
  12. Delgado AF, 2008, CLINICS, V63, P357, DOI 10.1590/S1807-59322008000300012
  13. Feferbaum R, 2009, CURR OPIN CLIN NUTR, V12, P245, DOI 10.1097/MCO.0b013e32832a3f43
  14. Foster KR, 1996, AM J CLIN NUTR, V64, P388
  15. FRISANCHO AR, 1974, AM J CLIN NUTR, V27, P1052
  16. Frisancho AR., 1999, ANTHROPOMETRIC STAND
  17. Gramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003
  18. Grippa RB, 2017, NUTRITION, V33, P91, DOI 10.1016/j.nut.2016.05.002
  19. Hulst J, 2004, CLIN NUTR, V23, P223, DOI 10.1016/S0261-5614(03)00130-4
  20. Israels T, 2008, PEDIATR BLOOD CANCER, V51, P626, DOI 10.1002/pbc.21697
  21. Johansen KL, 2003, AM J CLIN NUTR, V77, P842
  22. Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012
  23. Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004
  24. Kyle UG, 2013, CLIN NUTR, V32, P294, DOI 10.1016/j.clnu.2012.08.001
  25. Leite HP, 2016, PEDIATR CRIT CARE ME, V17, pE50, DOI 10.1097/PCC.0000000000000596
  26. LUKASKI HC, 1985, AM J CLIN NUTR, V41, P810
  27. Mauricio SF, 2016, NUTR CANCER, V68, P949, DOI 10.1080/01635581.2016.1188971
  28. Menezes FD, 2012, NUTRITION, V28, P267, DOI 10.1016/j.nut.2011.05.015
  29. Moisey LL, 2013, CRIT CARE, V17, DOI 10.1186/cc12901
  30. Norman K, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.024
  31. Norman K, 2012, CLIN NUTR, V31, P854, DOI 10.1016/j.clnu.2012.05.008
  32. Ong C, 2014, CLIN NUTR, V33, P191, DOI 10.1016/j.clnu.2013.12.010
  33. Camargo DAP, 2017, NUTR CANCER, V69, P601, DOI 10.1080/01635581.2017.1299880
  34. Pichard C, 2004, AM J CLIN NUTR, V79, P613
  35. Ravasco P, 2002, CLIN NUTR, V21, P73, DOI 10.1054/clnu.2001.0508
  36. Reilly JJ, 2017, ARCH DIS CHILD, V102, P1, DOI 10.1136/archdischild-2016-311682
  37. Ruiz-Margain A, 2015, DIGEST LIVER DIS, V47, P309, DOI 10.1016/j.dld.2014.12.015
  38. Shann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317
  39. Soler-Cataluna JJ, 2005, CHEST, V128, P2108, DOI 10.1378/chest.128.4.2108
  40. STEVENSON RD, 1995, ARCH PEDIAT ADOL MED, V149, P658, DOI 10.1001/archpedi.1995.02170190068012
  41. Stobaus N, 2012, BRIT J NUTR, V107, P1217, DOI 10.1017/S0007114511004028
  42. Stratton RJ, 2007, EUR J GASTROEN HEPAT, V19, P353, DOI 10.1097/MEG.0b013e32801055c0
  43. Thibault R, 2016, INTENS CARE MED, V42, P1445, DOI 10.1007/s00134-016-4468-3
  44. Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/cc13189
  45. Zamberlan P, 2011, JPEN-PARENTER ENTER, V35, P523, DOI 10.1177/0148607110386610

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/36